🇺🇸 Zegerid in United States

FDA authorised Zegerid on 15 June 2004

Marketing authorisations

FDA — authorised 15 June 2004

  • Application: NDA021636
  • Marketing authorisation holder: SALIX
  • Status: supplemented

FDA — authorised 27 February 2006

  • Application: NDA021849
  • Marketing authorisation holder: SALIX
  • Status: approved

FDA — authorised 1 December 2009

  • Application: NDA022281
  • Marketing authorisation holder: RILEY CONSUMER
  • Status: supplemented

FDA — authorised 15 July 2016

  • Application: ANDA201361
  • Marketing authorisation holder: PERRIGO R AND D
  • Status: supplemented

FDA

  • Status: approved

Zegerid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Zegerid approved in United States?

Yes. FDA authorised it on 15 June 2004; FDA authorised it on 27 February 2006; FDA authorised it on 1 December 2009.

Who is the marketing authorisation holder for Zegerid in United States?

SALIX holds the US marketing authorisation.